RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Evotec
E

Evotec portfolio

Evotec has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Capital in their rounds: $246M.
Latest deal: Aptadir Therapeutics · Sep 29, 2026.
About this page

Its most recent investment on record is Aptadir Therapeutics's $45M Seed round in September 2026, alongside Crescent Enterprises, XGEN Venture, CDP Venture Capital and 6 others. By category, its portfolio leans toward Health and bio (2) and Logistics and mobility (1). It has co-invested with HTGF, Seventure Partners and Fund+, most often HTGF (2 rounds).

What Evotec invests in

Evotec recent investments

CompanyRoundDateAlongside
AAptadir TherapeuticsSeed · $45MCrescent Enterprises, XGEN Venture, CDP Venture Capital +6
TTubulisSeries B+ · $138MHTGF, EQT Life Sciences (lead), Fund+ +6
TTubulisSeries B+ · $63MHTGF, BioMedPartners, Fund+ +5

How Evotec invests

StageDealsCapital in rounds
Series B+ 2 67%$201M
Seed 1 33%$45M
YearDealsCapital in rounds
2022 1 33%$63M
2024 1 33%$138M
2026 1 33%$45M

Evotec portfolio companies

CompanyRound with EvotecTotal raisedLatest raise
AAptadir Therapeutics
Health and bio
Seed · $45M$45MSep 29, 2026
Seed
TTubulis
Health and bio
Series B+ · $138M$573MOct 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name Evotec. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Evotec, which is a subset of its real portfolio. API: /api/v1/investors/evotec (get a free API key). More: the most active VC firms and new venture capital funds.